semaglutide germantown wi Medical Weight Loss GLP-1 in Wisconsin (WI) Semaglutide Flex-Dose 3 mL Injectable
Description
This case highlights the potential for drug-induced cutaneous lupus erythematosus (DICLE) associated with immune-modulating medications such as semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA).

GLP-1 receptor agonists have changed the way obesity and metabolic disease are treated
As of early 2026, only 13 state Medicaid programs cover GLP-1 medications for weight loss, down from 17 states at the start of the year California, New Hampshire, Pennsylvania, and South Carolina dropped coverage on January 1, 2026, citing budgetary constraints from the high cost of medications like Ozempic, Wegovy, and Zepbound

This article first appeared on GuruFocus

In the eyes of some patients who feel especially empowered and health-bent, the medical home might be the family home

Such practices have opened the gateway for considerable potential for abuse
